Medical equipment industry
MedSource Technologies, a provider of engineering, manufacturing, and supply-chain management services to the medical device industry, has been acquired by UTI Corp. for $230 million. The deal, led by DLJ Merchant Banking Partners, a private equity unit of Credit Suisse First Boston, combines the two companies to create a leader
Medical equipment industry
MedSource Technologies, Inc., a leading provider of engineering and manufacturing services and supply chain management solutions to the medical device industry, has entered into a definitive merger agreement to be acquired by UTI Corporation. Under the agreement, MedSource common stockholders will receive $7.10 per share in cash, representing a
Medical equipment industry
Boston Scientific Corporation has announced financial results for its first quarter ended March 31, 2004, showcasing a 34% increase in net sales to $1.082 billion compared to $807 million for the same period in 2003. The company's TAXUS Express2 paclitaxel-eluting coronary stent systems played a significant role
Medical equipment industry
Boston Scientific Corporation, a worldwide developer and manufacturer of medical devices, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Express(R) Biliary SD Monorail(R) Premounted Stent System for the treatment of malignant biliary tumors. This innovative
Pharmaceutical industry
Morphotek Inc., a biotechnology company specializing in the development of protein and antibody products, has announced the successful development of a high-titer antibody producing cell line in collaboration with Centocor, Inc. This achievement resulted in an undisclosed milestone payment to Morphotek. The cell line was developed using Morphotek's
Pharmaceutical industry
Creative Source Concepts, a wholly-owned subsidiary of JPC, has launched the Vision Program, a specialized purchasing program for the healthcare diagnostic imaging community. This innovative strategy aims to deliver incremental value to diagnostic imaging centers, enabling them to get the most out of their purchases and meet the demand in
Medical equipment industry
QMed, Inc. has signed a multi-year contract with Western Health Advantage (WHA) to provide diabetes and coronary artery disease management programs to patients and physicians of WHA. This contract marks an important milestone for QMed, expanding its commercial health plan book of business and accelerating the number of lives under
Medical equipment industry
Neoprobe Corp., a developer of oncology and cardiovascular surgical and diagnostic products, is set to meet with the U.S. Food and Drug Administration (FDA) on April 15, 2004, to discuss the submission of additional clinical information for RIGScan CR49. The meeting aims to review procedures for completing further analysis
Pharmaceutical industry
DePuy Mitek, a leading manufacturer of surgical sports medicine devices, has introduced the VAPR 3 LoPro Large Diameter Suction (LDS) Electrode, which demonstrated a 23 percent greater tissue removal rate than currently available in the market. This new electrode is designed to meet the needs of orthopaedic surgeons for high-performance
Pharmaceutical industry
Merit Medical Systems Inc. will be replacing Rainbow Technologies Inc. in the S&P SmallCap 600 after the close of trading on Monday, March 15, 2004. This move follows the acquisition of Rainbow Technologies by SafeNet Inc., a transaction that is still subject to shareholder approval. Merit Medical Systems,
Medical equipment industry
In a move to provide investors with insight into potentially profitable short-term stock opportunities, StockPickReport.Com has released a list of stock recommendations. These recommendations are based on a proprietary unbiased system of technical analysis and are designed to reflect the analyst's opinion of a stock's
Medical equipment industry
Angiotech Pharmaceuticals' partner, Boston Scientific Corporation, has received FDA approval to market the TAXUS Express2 paclitaxel-eluting coronary stent system in the United States. This breakthrough therapy will significantly impact the lives of thousands of patients with cardiovascular disease. The TAXUS system, launched in Europe and other international markets in
